Despite the ongoing war, Ukraine reaffirms its commitment to evidence- and rights-based drug policy, expanding harm reduction, access to essential medicines and mental health support under its new Strategy to 2030.
Austria’s CheckIt! has offered lab-based drug testing and confidential counselling for more than two decades — building trust and preventing harm where prohibition has failed.
Marie Nougier exposes how punitive drug laws devastate women’s lives, fueling mass incarceration and inequality — and calls for feminist, humane, evidence-based drug policies rooted in care, not punishment.
Bolivia's campaign to remove the coca leaf from the list of the world’s most dangerous drugs highlights the plant's cultural, medicinal and economic importance — and its potential to reshape global drug policy.
IDPC joined INPUD and HRI in expressing deep concern over plans to “sunset” UNAIDS, warning that its premature closure would endanger progress on harm reduction and human rights.
IDPC joins civil society worldwide in calling on Canada to reaffirm its leadership in global health by pledging CAD$1.37 billion to the Global Fund, saving millions of lives and strengthening global resilience.
International cooperation through the Association of Southeast Asian Nations presents an opportunity to consistently align regional drug policy with human rights standards.
Explicit recognition of widespread public health harms of repressive control efforts could positively influence expert recommendation on the schedule of the coca leaf.
Amid a rapidly shifting diplomatic landscape, Colombia has emerged as a potential leader of global non-prohibitionist drug policy reform, but the sustainability of these efforts remains uncertain.
South African directive to end unnecessary syringe and needle confiscation prompts support from Special Rapporteur Mofokeng, citing the importance of rights-based intervention.
